(19)
(11) EP 3 790 573 A1

(12)

(43) Date of publication:
17.03.2021 Bulletin 2021/11

(21) Application number: 19799475.9

(22) Date of filing: 10.05.2019
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
(86) International application number:
PCT/US2019/031832
(87) International publication number:
WO 2019/217897 (14.11.2019 Gazette 2019/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 11.05.2018 US 201862670615 P
19.07.2018 US 201862700804 P

(71) Applicant: HDL Therapeutics, Inc.
Vero Beach, FL 32960 (US)

(72) Inventors:
  • BREWER Jr., Hollis, Bryan
    Potomac, MD 20854 (US)
  • MATIN, Michael, M.
    Short Hills, NJ 07078 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) METHODS FOR PROPHYLACTICALLY PREVENTING, SLOWING THE PROGRESSION OF, OR TREATING CEREBRAL AMYLOID ANGIOPATHY, ALZHEIMER'S DISEASE AND/OR ACUTE STROKE